biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > BTI:TSXV: Announces $200,000 Non-Brokered Private Placement

<< Previous

Bullboard Posts

Next >>

Comment by frohlir944on Jan 30, 2021 12:53am

158 Views

Post# 32427317

RE:RE:RE:RE:RE:RE:RE:RE:BTI:TSXV: Announces $200,000 Non-Brokered Private Placement

He's always been a toxic hater. Never takes responsibility for his actions, wants the whole world to feel sorry for him and absolutely doesn't understand even a simple concept like that if you run a lemonade stand and put up a sign that says "really shitty lemonade", that people probably won't buy any. Yet he's willing to constantly say it about his investment and then act surprised that people aren't lining up to buy shares. Everyone else is responsible, but his toxic actions have zero responsibility.

<< Previous

Bullboard Posts

Next >>

NervGen Pharma: Proof that NVG-291 works?